Successful Treatment with Direct-Acting Antiviral Agents of Hepatitis C in the Setting of End-Stage Renal Disease

dc.contributor.authorEtik, Digdem Ozer
dc.contributor.authorSuna, Nuretdin
dc.contributor.authorOcal, Serkan
dc.contributor.authorSelcuk, Haldun
dc.contributor.authorDagli, Ulku
dc.contributor.authorColak, Turan
dc.contributor.authorHilmioglu, Fatih
dc.contributor.authorBoyacioglu, Sedat
dc.contributor.authorHaberal, Mehmet
dc.contributor.orcID0000-0002-4724-0728en_US
dc.contributor.orcID0000-0001-6234-7788en_US
dc.contributor.orcID0000-0003-3719-9482en_US
dc.contributor.orcID0000-0002-8445-6413en_US
dc.contributor.orcID0000-0003-0664-0976en_US
dc.contributor.orcID0000-0002-8372-7840en_US
dc.contributor.orcID0000-0002-6440-5686en_US
dc.contributor.orcID0000-0002-9370-1126en_US
dc.contributor.orcID0000-0002-3462-7632en_US
dc.contributor.researcherIDAAJ-4707-2021en_US
dc.contributor.researcherIDAAI-8822-2021en_US
dc.contributor.researcherIDABH-4817-2020en_US
dc.contributor.researcherIDAAJ-6976-2021en_US
dc.contributor.researcherIDS-4068-2018en_US
dc.contributor.researcherIDAAJ-8554-2021en_US
dc.contributor.researcherIDAAJ-4437-2021en_US
dc.contributor.researcherIDAAE-7637-2021en_US
dc.contributor.researcherIDAAJ-8097-2021en_US
dc.date.accessioned2023-05-23T08:27:22Z
dc.date.available2023-05-23T08:27:22Z
dc.date.issued2018
dc.identifier.endpageS909en_US
dc.identifier.issn0041-1337en_US
dc.identifier.issueSupplement 7en_US
dc.identifier.startpageS909en_US
dc.identifier.urihttp://hdl.handle.net/11727/9107
dc.identifier.volume102en_US
dc.identifier.wos000444541201737en_US
dc.language.isoengen_US
dc.relation.isversionof10.1097/01.tp.0000544016.62771.b1en_US
dc.relation.journalTRANSPLANTATIONen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleSuccessful Treatment with Direct-Acting Antiviral Agents of Hepatitis C in the Setting of End-Stage Renal Diseaseen_US
dc.typeconferenceObjecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: